PALB2 and invasive breast carcinoma: This year, however, a study including 15,104 prospectively followed women treated with ipsilateral surgery for invasive breast cancer reported a 35% 10-year cumulative incidence of contralateral breast cancer for PALB2 truncating variant carriers with ER-negative breast cancer [42].